Application no. and date | 16778330.7 (espacenet) (Federated) (European Patent Register), 20161004 | Patent/reg. no. and date | DK/EP 3359189, 20210623 | Publication date | 20180815 | Priority no. and date | GB 201517550, 20151005, GB 201519105, 20151029 | EP pub. no. and date |
EP 3359189 20180815 | Effective date | | Applicant/owner | Fredax AB, Hans Jonas väg 2
237 37 Bjärred, SE | Applicant ref. no. | FREQ/P61995EP | Inventor | AXELSSON, Anders, Anesväg 5
237 31 Bjärred, SE, SJÖSTRÖM, Kjell, Rörläggarevägen 16
SE-227 30 Lund, SE, MALMBORG HAGER, Cecilia Ann-Christin, Jönköpingsgatan 83
252 50 Helsingborg, SE, STRAND, Sven-Erik, Tenorgränd 3
224 68 Lund, SE, LAMMINMÄKI, Urpo Juhani, Mestarintie 27
21410 Vanhalinna, FI, TRAN, Amanda Thuy, Liljeholmstorget 12
117 61 Stockholm, SE | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 51/10 (2006.01) , A61P 35/00 (2006.01) , C07K 16/30 (2006.01) | Title | HUMANIZED ANTI PSA (5A10) ANTIBODIES | Int. application no. | EP2016073684 | Int. publication no. | WO2017060247 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|